Human platelets express gangliosides with LKE activity and ABH blood group activity

Transfusion

Volumn 41, Issue 4, 2001, Pages 504-516

  Cooling, Laura L W ^a,b,c   Zhang, DeSheng ^a,b   Koerner, Theodore A W ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GLYCOSPHINGOLIPID;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP AB; BLOOD GROUP TYPING; CARBOHYDRATE ANALYSIS; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ABO BLOOD-GROUP SYSTEM; ANTIGENS, HUMAN PLATELET; BLOOD PLATELETS; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; HUMANS;

EID: 0035032849     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41040504.x     Document Type: Article

References (77)

1. Gangliosides: Structure, isolation and analysis
2. Glycosphingolipids: Structure, biological source, and properties
3. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion and transmembrane signaling
4. Lewis X and sialyl Lewis X glycosphingolipids
5. x having tetraosyl to octaosyl core
6. Monsialogangliosides or human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin
7. Bioactive gangliosides: Differentiation inducers for hematopoietic cells and their mechanism(s) of actions
8. Modulation of human myelopoiesis by human gangliosides
9. Tumor-associated glycolipid antigens, their metabolism and organization
10. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
11. Interaction of Clostridium perfringens δ toxin with erythrocyte and liposome membranes and relation with the specific binding to the ganglioside GM2
12. The role of the ganglioside GD1a as a receptor for Sendai virus
13. Animal glycosphingolipids as membrane attachment sites for bacteria
14. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19
15. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy
16. Autoimmune mechanisms in peripheral neuropathies
17. Human monoclonal antibodies directed against carbohydrates
18. Neolacto (Type 2 chain)-sialoautoantigens recognized by human cold agglutinins
19. Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria
20. Hemolysis of human erythrocytes is a new bioactivity of gangliosides
21. The effect of thrombin on the organization of human platelet membrane glycosphingolipids. The sphingosine composition of platelet glycolipids and ceramides
22. Ganglioside content of human platelets - Differences in resting and activated platelets
23. The effect of storage on the ganglioside content of human platelets
24. Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins
25. Ganglioside GM3 promotes megakaryocytic differentiation and platelet production
26. Ganglioside GM3 can induce megakaryocytoid differentiation of human leukemia cell line K562 cells
27. The human platelet dense granule: Serotonin uptake, tetrabenazine binding, phospholipid and ganglioside profiles
28. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura
29. Identification of α-galactose (α-fucose)-asialo-GM1 glycolipid expressed by subsets of rat dorsal root ganglion neurons
30. Ganglio-series histo-blood group A-active glycolipids: In vitro biosynthesis, structural characterization and production of monoclonal antibodies defining these compounds
31. The fucosylated ganglioside FUCGM1 mimics the receptor function of GM1 ganglioside for cholera toxin
32. Isolation and characterization of novel glycolipids with blood group A-related structures: Galactosyl-A and sialosylgalactosyl-A
33. Characterization of an epitope (determinant) structure in a developmentally regulated glycolipid antigen defined by a cold agglutinin Fl, recognition of α-sialosyl and α-L-fucosyl groups in a branched structure
34. Four antigenic variants of blood group A glycolipid: Examples of highly complex, branched chain glycolipid of animal cell membrane
35. Glycolipid- and glycoprotein-based blood group A antigen expression in human thrombocytes. A1/A2 difference
36. Biochemical characterization of A blood group activity on human platelets
37. Separation of gangliosides on a new type of anion-exchange resin
38. A new monoclonal anti-A antibody Birma-1. A potent culture supernatant which agglutinates Ax cells, but does not give undesirable reactions with B cells
39. A new monoclonal anti-A. Culture supernatants with the performance of hyperimmune human reagents
40. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain
41. 6): A useful probe for determining different glycosylation patterns between normal and transformed human fibroblasts
42. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1
43. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen, stage-specific embryonic antigen 3
44. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes for a unique globo-series ganglioside isolated from human teratocarcinoma
45. Red cell antigens P (globoside) and Luke: Identification by monoclonal antibodies defining the murine stage-specific embryonic antigens-3 and -4 (SSEA-3 and SSEA-4)
46. A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2
47. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells
48. GD3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody
49. The recognition of three different epitopes for the H-type 2 human blood group determinant by lectins of Ulex europaeus, Galactia tenuiflora and Psophocarpus tetragonolobus (Winged Bean)
50. Antibodies against platelet glycosphingolipids: Detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes
51. Action of Arthrobacter ureafaciens sialidase on sialoglylcolipid substrates. Mode of action and highly specific recognition of the oligosaccharide moiety of ganglioside GM1
52. Action of Clostridium perfringens neuraminidase on gangliosides GM1 and GM2 above and below the critical micelle concentration of substrate
53. Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetyl-neuraminic acid
54. A novel glycosphingolipid-degrading enzyme cleaves of the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids
55. Rapid separation and quantification of lipid classes by high performance liquid chromatography and mass (light-scattering) detection
56. Megakaryocytic and erythrocytic cell lines share a common precursor cell
57. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids
58. Revised structure for the disialosyl globo-series gangliosides of human erythrocytes and chicken skeletal muscle
59. Isolation of Luke antigen and related, novel gangliosides from human red cells and kidney
60. Common tetrasaccharide epitope NeuAcα2-3Galβ1-3(NeuAcα2-6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities
61. Glycolipid core-structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells
62. Glycosphingolipid carriers of carbohydrate antigens of human myeloid cells recognized by monoclonal antibodies
63. Blood group ABH and Ii antigens of human erythrocytes: Chemistry, polymorphism and their developmental change
64. Glycosphingolipids of K562 cells: A chemical and immunological analysis
65. Human platelets are defective in processing of cholera toxin
66. Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes
67. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization
68. 2 enzymes, and type 3 chain expression in relation to secretor status
69. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial
70. Monoclonal antibodies directed to the blood group A associated structure, galactosy-A: Specificity and relation to the Thomsen-Friedenreich antigen
71. The role of sialoglycoconjugates in the aging and sequestration of red cells from circulation
72. The natural anti-Gal antibody, the B-like antigen, and human red cell aging
73. Molecular mimicry in the recognition of glycosphingolipids by Galα1-3Galβ1-4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti-αGalactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor
74. The globo-series glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins